277 related articles for article (PubMed ID: 37454557)
1. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods.
Sijithra PC; Santhi N; Ramasamy N
Eur J Radiol; 2023 Sep; 166():110972. PubMed ID: 37454557
[TBL] [Abstract][Full Text] [Related]
2. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy.
Toft J; Hadden WJ; Laurence JM; Lam V; Yuen L; Janssen A; Pleass H
Eur J Radiol; 2017 Jul; 92():17-23. PubMed ID: 28624015
[TBL] [Abstract][Full Text] [Related]
3. Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.
Enriquez JS; Chu Y; Pudakalakatti S; Hsieh KL; Salmon D; Dutta P; Millward NZ; Lurie E; Millward S; McAllister F; Maitra A; Sen S; Killary A; Zhang J; Jiang X; Bhattacharya PK; Shams S
JMIR Med Inform; 2021 Jun; 9(6):e26601. PubMed ID: 34137725
[TBL] [Abstract][Full Text] [Related]
4. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.
Qureshi TA; Javed S; Sarmadi T; Pandol SJ; Li D
Chin Clin Oncol; 2022 Feb; 11(1):1. PubMed ID: 35144387
[TBL] [Abstract][Full Text] [Related]
6. Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances.
Barat M; Marchese U; Pellat A; Dohan A; Coriat R; Hoeffel C; Fishman EK; Cassinotto C; Chu L; Soyer P
Can Assoc Radiol J; 2023 May; 74(2):351-361. PubMed ID: 36065572
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence to predict T4 stage of pancreatic ductal adenocarcinoma using CT imaging.
Miao Q; Wang X; Cui J; Zheng H; Xie Y; Zhu K; Chai R; Jiang Y; Feng D; Zhang X; Shi F; Tan X; Fan G; Liang K
Comput Biol Med; 2024 Mar; 171():108125. PubMed ID: 38340439
[TBL] [Abstract][Full Text] [Related]
8. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
9. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma.
Zhou T; Man Q; Li X; Xie Y; Hou X; Wang H; Yan J; Wei X; Bai W; Liu Z; Liu J; Hao J
Cancer Biol Med; 2023 Mar; 20(3):196-217. PubMed ID: 36971107
[TBL] [Abstract][Full Text] [Related]
11. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of
Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
[TBL] [Abstract][Full Text] [Related]
14. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
16. BEYOND TRADITIONAL TOOLS: EXPLORING CONVOLUTIONAL NEURAL NETWORKS AS INNOVATIVE PROGNOSTIC MODELS IN PANCREATIC DUCTAL ADENOCARCINOMA.
Ahmed HS
Arq Gastroenterol; 2024; 61():e23107. PubMed ID: 38511794
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma.
Hayashi H; Uemura N; Matsumura K; Zhao L; Sato H; Shiraishi Y; Yamashita YI; Baba H
World J Gastroenterol; 2021 Nov; 27(43):7480-7496. PubMed ID: 34887644
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence for the detection of pancreatic lesions.
Anta JA; Martínez-Ballestero I; Eiroa D; García J; Rodríguez-Comas J
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1855-1865. PubMed ID: 35951286
[TBL] [Abstract][Full Text] [Related]
19. PET/CT in brachytherapy early response evaluation of pancreatic ductal adenocarcinoma xenografts: comparison with apparent diffusion coefficient from diffusion-weighted MR imaging.
Liu Y; Liu M; Liu X; Zhou Y
Abdom Radiol (NY); 2019 Mar; 44(3):950-957. PubMed ID: 30315322
[TBL] [Abstract][Full Text] [Related]
20. Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma.
Zhang Y; Huang ZX; Song B
World J Gastroenterol; 2021 Jun; 27(22):3037-3049. PubMed ID: 34168406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
